CHANG, FENG

Release date:2016-05-25  Release:

CHANG, FENG 

Associate Professor of Social and Administrative Pharmacy /Business Management

School of International Pharmaceutical Business

Phone: 86-25-86185188

Email: cf@cpu.edu.cn

Research Summary

Professor CHANG’s research focuses on the drug purchasing and bidding , medical and health reform ,medical insurance system and drug pricing.He is a columnist for Xinhuanet,and has repeatedly accepted the interview with CCTV and  the Xinhua News Agency.He has hosted 30 

national and medical business commission subjects, and has published more than 100 papers with high quality.  

Education

2012-2013     Visiting scholar, University of Cincinnati,USA

2003-2010     Ph.D., Management Science, Southeast University

1999-2002     M.S.,  MBASoutheast University

1991-1995     B.S.,   MerchandisingAnhui Finance and Economics University

Academic Experience

2015-Present  Member of Pharmaceutical Policy Expert Bank of National health and family planning commission

2015-Present Vice-president of Pharmaceutical price professional committeeThe price association of Jiangsu

2013-Present  Expert of Pharmaceutical price professional committeeThe price association of China

2013-Present  Director, GuangDong pharmaceutical  price association

1995- PresentSchool of International Pharmaceutical Business, China Pharmaceutical University   

Awards and Honors

2014   The sixth Xue Muqiao Price Research award(the first  authorChina's highest award for price field), The price association of China

2014    Second Prize of excellent project award  ,forstudy on the unified pricing mechanism of cheap drugsJiangsu Province

2013  Second Prize of excellent achievement ,for study on pharmaceutical price index ,Guangdong pharmaceutical price Association

2012    Second Prize of excellent achievementforstudy on the drug cost and pricing mechanism of cold chain,Guangdong pharmaceutical price association

2012    Excellent Achievement Prize ,The price association of China

Publications

Scientific Research Project

直接连接符 5

  • Study on the price of non prescription drug payment”(2015) supported by Tianjin price association

  •  “Study on the price system of drug payment”(2014) supported by the price association of China

  • Study on the quality evaluation system of essential drugs”(2013) supported by China food and drug administration

  • Study on the  international reference pricing method of drug”(2013) supported by the price association of China

  • The impact of the new version of GMP on drug prices”(2013) supported by Guangdong pharmaceutical price association

  • Study on pharmaceutical price index”(2012) supported by Guangdong pharmaceutical price association

  •  “Study on the preparation of chemical drug price index”(2011) supported by the price association of China

  • Study on the improvement of drug price management system”(2011) supported by the price association of China

  •  “Study on the drug cost and pricing mechanism of cold chain”  (2011) supported by Guangdong pharmaceutical price association

  • Study on the standard of drug price release and medical insurance payment”(2015) supported by Bayer

  • The application of the international drug price for the reform of drug formation mechanism  ”(2015) supported by Novartis

  • An empirical study of international reference pricing ”(2015) supported by Roche

  • Study on the role and application of market mechanism in drug price management ”(2014) supported by Roche

  • Study on the unified pricing mechanism of cheap drugs”(2013) supported by Bayer

  • Drug price classification management”(2013) supported by Novartis


Publications (As the first author)

直接连接符 6

  • Feng Chang(2015.12), “Study on the health care system and operation mode of South Korea”, Chinese Journal of health policy research, 2015(12)

  • Feng Chang(2015.12), “Study on the construction of basic drug monitoring evaluation system-based on the Network Analysis”, Chinese Journal of health management, 2015, 32(12):918-921

  • Feng Chang(2015.12), “Enlightenment of the overseas drug price monitoring mode”, Chinese Journal of health economics , 2015, 34(12)

  • Feng Chang(2015.11), “Introduction and enlightenment of the drug biding and purchasing system in the EU”, Chinese Journal of Pharmaceuticals, 2015, 46(11):1254-1258

  • Feng Chang(2015.10), “Enlightenment of the implementation of America centralized purchasing organization”, Chinese Journal of health economics , 2015, 34(10)

  • Feng Chang(2015.9),”Enlightenment of typical countries’ new drug pricing mechanism based on value”, Chinese Journal of New Drugs, 2015(18):2047-2051

  • Feng Chang(2015.9), “International experience and enlightenment of Drug payment price formulation “, Journal of price theory and Practice, 2015(9):49-51

  • Feng Chang(2015.8), “Enlightenment of  Japanese Medicare drug payment price adjustment mechanism”, Chinese Journal of Pharmaceuticals, 2015, 46(8):915-920

  • Feng Chang(2015.7), “Enlightenment of the Germany drug reference price system to the construction of our medical insurance payment standard ”, Chinese Journal of health policy research, 2015(7):55-60

  • Feng Chang(2015.7), ”The application of international reference price of drug“, Journal of price theory and Practice, 2015(7):14-16

  • Feng Chang(2015.5),”Experience and enlightenment of the revolution of the South Korea’s drug list and price negotiation reform”, Journal of price theory and Practice, 2015(5):97-99

  • Feng Chang(2015.4),”Discussion on orphan drug price regulation based on the perspective of drug pricing and reimbursement”, Chinese Journal of New Drugs, 2015(7):741-744

  • Feng Chang(2015.4), “Discussion on the effect on the purchasing behavior of patients with chronic diseases- empirical research under the theory of Planned Behavior ”, Chinese Journal of general medicine, 2015(12):1431-1435

  • Feng Chang(2015.4),” The study of organic cohesion strategy of the top design and operational level of drug price reform ”, Journal of price theory and Practice, 2015(4):23-24

  • Feng Chang(2015.4), “Enlightenment of American medical devices monitoring used for humanitarianism;Academic Journal of Guangdong College of Pharmacy, 2015, 31(3):367-371

  • Feng Chang(2015.3), “Enlightenment of the Medical voucher system in Hong Kong and Macao”, Chinese Journal of health policy research, 2015, 8(3):40-45

  • Feng Chang(2014.11),”Effect on the cost of Sterile Drug under the condition of the Version 2010 GMP”, Chinese Journal of Pharmaceuticals, 2014, 45(11)

  • Feng Chang(2014.9), “Analysis and enlightenment of international reference pricing system of  the European countries”, Chinese Journal of health economics, 2014, 33(9):94-96

  • Feng Chang(2014.6),” A comparative study of the drug price of the import patent drugs and primary drug in our country”, Journal of price theory and Practice, 2014(6):51-53

  • Feng Chang(2014.5),”Enlightenment of the international reference pricing mechanism of Japanese new drugs”, Chinese Journal of New Drugs,  2014(5):510-512,

  • Feng Chang(2014.5),” Research on the price warning of Chinese herbal medicines –based on the ARMA prediction model”, Chinese Journal of Chinese Materia Medica, 2014, 39(9):1721-1723

  • Feng Chang(2014.4),”Enlightenment of the international reference pricing method  of drugs –based on Canada, Japan and Dutch ”, Journal of price theory and Practice, 2014(4):92-95

  • Feng Chang(2014.4),” Preview of the price index in the field of medicine in the America Denmark and Switzerland”, Journal of modern business and trade, 2014(4):37-38

  • Feng Chang(2014.2),”Evaluation on the drug quality with the method of Grey Cluster Analysis ”, Chinese Journal of New Drugs, 2014(2):130-133

  • Feng Chang(2014.2),”Study on quality monitoring of basic drugs ”, Chinese Journal of prescription drugs, 2014(2):10-12

  • Feng Chang(2013.12),”Suggestion of drug price management based on Version 2010 GMP”, Journal of price theory and Practice, 2013(12):50-51

  • Feng Chang(2013.12),”Review of the entry of generic drugs with the effect of drug advertisement”, Journal of modern business and trade, 2013(12):57-59

  • Feng Chang(2013.10), “Analysis and strategy of the burden on the availability of cheap drugs”, Chinese Journal of Pharmaceuticals, 2013, 44(10)

  • Feng Chang(2013.8),”Study on the influence factors of doctors’ behavior of prescription”, Journal of science and education wenhui academic, 2013(8):45-46

  • Feng Chang(2013.7), “The contract design of the anti-lateral conspiracy in the centralized bidding and purchasing of drugs ”, Chinese Journal of pharmacy, 2013(28):2614-04

  • Feng Chang(2013.6),”Management of the prescription advertising to customers in New Zealand ”, Health Economics Research; 2013(6):32-33

  • Feng Chang(2013.5), “Study on the subsidy mechanism of medical institutions using essential drugs”, Chinese Journal of pharmacy , 2013(20):1830-1833

  • Feng Chang(2013.5),”Study on the regulation of medicine in our country and entrepreneurship”, Journal of enterprise technology development, 2013, 32(5):35-36

  • Feng Chang(2013.4),”Analysis on the availability of uniform pricing on basic drugs”, Chinese Journal of drug evaluation, 2013, 30(2):117-120

  • Feng Chang(2013.4),”Study on the attendance behavior of college students-based on the construction of planned behavior theory model and the design of intervention experiment ”, Journal of modern business and trade, 2013(4):145-146

  • Feng Chang(2013.3),”Review on the drug advertisement to customers in the America and Canada”, Journal of modern business and trade, 2013(3):73-74

  • Feng Chang(2013.2),” Questionnaire based on the influencing factors of medication compliance of community hypertension patients based on TPB  ”, Chinese Journal of Medical Sciences, 2013, 3(2):58-59

  • Feng Chang(2013.2),”Relationship between the drug advertisement to customers and pharmaceutical sales”, Journal of modern business and trade, 2013(2):82-83

  • Feng Chang(2012.12), “Study on medication compliance of patients with essential hypertension”, Modern medicine journal of hygiene, 2012, 28(24):3771-3773

  • Feng Chang(2012.12), “Review on the theory of medication compliance behavior in foreign countries”, Journal of science and education wenhui academic, 2012(36):126-126

  • Feng Chang(2012.1), “Study on the incentives of pharmaceutical companies producing essential drugs ”, Chinese Pharmaceutical Affairs, 2012(1):17-19

  • Feng Chang(2011.10), “The incentive problem of the basic drug usage from the demand”, Shanghai Journal of Medicine, 2011, 32(10):505-507

  • Feng Chang(2010.8),” Discussion on drug price management mechanism - from the perspective of the combination of drug pricing and reimbursement regulation”, Journal of price theory and Practice, 2010(8):30-31

  • Feng Chang(2010.7),”Research on the reaction of small and medium enterprises to the reform of drug circulation environment”, Capital Medicine Journal, 2010(14)

  • Feng Chang(2010.6),” The development of American commercial medical insurance model”, Shanghai Journal of Medicine, 2010, 31(6):275-278

  • Feng Chang(2010.3),” The application of price cap regulation in the field of drug pricing”, Chinese Journal of pharmaceutical economics, 2010(3):54-59

  • Feng Chang(2010.2),” Study on the policy of drug price management for physicians and pharmacists in foreign countries”, Chinese Journal of pharmaceutical economics, 2010(1)

  • Feng Chang(2009), “Analysis of the foreign drug reimbursement regulation policy”, Chinese Journal of pharmacy, 2009:3076-3078

  • Feng Chang(2009.9), “Analysis on the drug price rule under The delineation of market conditions”, Soft Science, 2009, 23(9):64-68

  • Feng Chang(2009.7), “Study on the social medical insurance compensation mechanism design”, Journal of Southeast University, 2009, 11(4):57-61

  • Feng Chang(2009.5), “Research on the development process of drug price management in China”, Chinese Journal of pharmaceutical economics, 2009(5)

  • Feng Chang(2009.4), “Review on domestic and international pharmaceutical price regulation policy “, Journal of price theory and Practice, 2009(4):49-50

  • Feng Chang(2009.2), “Review of researches on drug reference pricing in foreign countries”, Journal of Hohai University(Philosophy and Social Sciences), 2009, 11(2):51-54

  • Feng Chang(2008.4), “Comparative study of domestic and foreign drug reference pricing models “, Chinese Journal of pharmaceutical economics, 2008(4)

  • Feng Chang(2008.2), “Strengthen the supervision of medical institutions  Balance the market power of drugs “, Chinese Journal of Pharmaceutical Technology & economy and management, 2008, 2(2):102-105


Publications (As the communication author)

直接连接符 1

  • Feng Chang(2015.3),”Effect on the diabetic patients of the devotion of different health education to ”, ChongQing Journal of Medicine, 2015(9):1244-1246

  • Feng Chang(2014.7), “Construction of patient choosing pharmacies behavior intention model-based on the planned behavior theory ”, Journal of pharmaceutical research, 2014(7):425-427

  • Feng Chang(2014.6), “Risk and prevention of none prescription Chinese patent drugs in self-medicine”, Chinese Journal of Pharmacy, 2014(23):2197-2199

  • Feng Chang(2013.11),“The effect of advertisement and price regulation on generic competition in drug market”, Journal of modern business and trade, 2013(11):89-91

  • Feng Chang(2013.10), “Study on the mechanism of drug value pricing in UK”, Shanghai Journal of Medicine, 2013(19):32-35

  • Feng Chang(2013.10),“Analysis of foreign pharmaceutical companies market positioning under the new ‘national essential drugs list’”, Journal of modern business and trade, 2013, 25(10):80-81

  • Feng Chang(2013.7),“Analysis of pricing strategies of independent pricing drugs -- based on the theory of product life cycle”, Journal of modern business and trade, 2013(7):74-75

  • Feng Chang(2013.7),“Study on the incentive mechanism of doctor's prescription behavior”, Journal of modern business and trade, 2013(7):163-165

  • Feng Chang(2013.6),“The definition and analysis of the stakeholders in the prescription behavior of doctors”, Journal of modern business and trade, 2013, 25(6):146-148

  • Feng Chang(2013.4),“Discussion on the basic drug risk and risk management mechanism”, Chinese Journal of Licensed Pharmacists, 2013, 10(4)

  • Feng Chang(2012.7),“An empirical analysis on the influencing factors of drug safety risk”, Chinese Journal of Licensed Pharmacists, 2012, 09(7):44-47

  • Feng Chang(2012.1),“Research and thinking on drug price management at home and abroad”, Chinese Journal of Licensed Pharmacists, 2012, 09(1)

  • Feng Chang(2011.10),”Study on the evaluation of drug risk assessment- based on risk management theory”, Chinese Journal of New Drugs, 2011(19):1843-1845

  • Feng Chang(2011.7),“Study on the evaluation index of the rationality of community drug use”, Chinese Journal of Licensed Pharmacists, 2011, 08(7):14-17

  • Feng Chang(2010.4),“Discussion on the application of PDCA circulation mode to promote the implementation of clinical pathway”, Journal of Health Science and soft science, 2010, 24(4):297-299

  • Feng Chang(2009,10), “Application of acquisition and benefit sharing system in the area of Traditional Chinese Medicine”, Chinese Journal of Pharmacy, 2009(30):2321-2323

  • Feng Chang(2008,6), “Effect of differential pricing on drug market”, Chinese Journal of pharmaceutical economics, 2008(6)

  • Feng Chang(2008,6), “Comparative analysis of drug pricing and compensation system in major European countries”, Chinese medicine technology economy and management, 2008, 2(6):83-86